Nautilus Biotechnolgy, Inc.
USD1.86
+0.07 (+3.91%)
CEO
Sujal Patel
IPO Date
2020-08-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.81
Prev. Close
$1.79
Day Low
$1.79
Day High
$1.87
52W Low
$0.62
52W High
$4.31
Market Cap
$0.24B
Volume
0.08M
| -3.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -24.0% | -20.8% | 0.13 | 19.39 | -5.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -18.4% | -16.5% | 0.10 | 27.57 | -3.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -13.8% | -12.6% | 0.08 | 60.09 | -8.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 52.6% | -18.4% | -0.16 | 25.73 | -23.0 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -53.3% | -51.9% | 15.23 | 34.62 | -6.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 12532.0% | 429.7% | 1.00 | 266.45 | 0.1 |
| -4.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -8.0% | -6.8% | 0.16 | 14.95 | -2.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.3% | -7.1% | 0.16 | 18.52 | -1.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.5% | -7.3% | 0.15 | 17.36 | -1.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.4% | -7.2% | 0.15 | 17.40 | -3.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.4% | -6.3% | 0.14 | 16.65 | -5.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.7% | -6.6% | 0.14 | 19.69 | -3.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.5% | -6.5% | 0.13 | 20.09 | -5.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -6.4% | -5.6% | 0.13 | 19.39 | -5.5 |